Three Years of Vestibular Infant Screening in Infants With Sensorineural Hearing Loss.


Journal

Pediatrics
ISSN: 1098-4275
Titre abrégé: Pediatrics
Pays: United States
ID NLM: 0376422

Informations de publication

Date de publication:
01 07 2022
Historique:
accepted: 23 02 2022
pubmed: 15 6 2022
medline: 6 7 2022
entrez: 14 6 2022
Statut: ppublish

Résumé

Although vestibular deficits are more prevalent in hearing-impaired children and can affect their development on many levels, a pediatric vestibular assessment is still uncommon in clinical practice. Since early detection may allow for timely intervention, this pioneer project has implemented a basic vestibular screening test for each six-month-old hearing-impaired infant in Flanders, Belgium. This study aims to report the vestibular screening results over a period of three years and to define the most important risk factors for abnormal vestibular screening results. Cervical Vestibular Evoked Myogenic Potentials with bone-conduction were used as a vestibular screening tool in all reference centers affiliated to the Universal Newborn Hearing Screening Program in Flanders. From June 2018 until June 2021, 254 infants (mean age: 7.4 months, standard deviation: 2.4 months) with sensorineural hearing loss were included. Overall, abnormal vestibular screening results were found in 13.8% (35 of 254) of the infants. The most important group at risk for abnormal vestibular screening results were infants with unilateral or bilateral severe to profound sensorineural hearing loss (20.8%, 32 of 154) (P < .001, odds ratio = 9.16). Moreover, abnormal vestibular screening results were more prevalent in infants with hearing loss caused by meningitis (66.7%, 2 of 3), syndromes (28.6%, 8 of 28), congenital cytomegalovirus infection (20.0%, 8 of 40), and cochleovestibular anomalies (19.2%, 5 of 26). The vestibular screening results in infants with sensorineural hearing loss indicate the highest risk for vestibular deficits in severe to profound hearing loss, and certain underlying etiologies of hearing loss, such as meningitis, syndromes, congenital cytomegalovirus, and cochleovestibular anomalies.

Identifiants

pubmed: 35698886
pii: 188271
doi: 10.1542/peds.2021-055340
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT05061069']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 by the American Academy of Pediatrics.

Auteurs

Sarie Martens (S)

Faculty of Medicine and Health Sciences, Departments of Rehabilitation Sciences, Ghent University, Ghent, Belgium.

Ingeborg Dhooge (I)

Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent University, Ghent, Belgium.
Department of Otorhinolaryngology, Ghent University Hospital, Ghent, Belgium.

Cleo Dhondt (C)

Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent University, Ghent, Belgium.

Saartje Vanaudenaerde (S)

Department of Otorhinolaryngology, Ghent University Hospital, Ghent, Belgium.

Marieke Sucaet (M)

Faculty of Medicine and Health Sciences, Departments of Rehabilitation Sciences, Ghent University, Ghent, Belgium.

Helen Van Hoecke (H)

Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent University, Ghent, Belgium.
Department of Otorhinolaryngology, Ghent University Hospital, Ghent, Belgium.

Els De Leenheer (E)

Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent University, Ghent, Belgium.
Department of Otorhinolaryngology, Ghent University Hospital, Ghent, Belgium.

Lotte Rombaut (L)

Department of Otorhinolaryngology, Ghent University Hospital, Ghent, Belgium.

An Boudewyns (A)

Faculty of Medicine and Translational Neurosciences, Department of Otorhinolaryngology, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium.

Christian Desloovere (C)

Department of Otorhinolaryngology, University Hospital Leuven, Leuven, Belgium.

Anne-Sophie Vinck (AS)

Department of Otorhinolaryngology, AZ Sint-Jan Bruges, Bruges, Belgium.

Sebastien Janssens de Varebeke (SJ)

Department of Otorhinolaryngology, Jessa Hospital, Hasselt, Belgium.

Dominique Verschueren (D)

Department of Otorhinolaryngology, AZ Maria Middelares, Ghent, Belgium.

Margriet Verstreken (M)

Department of Otorhinolaryngology, GZA Sint-Augustinus, Antwerp, Belgium.

Ina Foulon (I)

Department of Otorhinolaryngology, University Hospital Brussels, Brussels, Belgium.

Charlotte Staelens (C)

Department of Otorhinolaryngology, AZ Delta Menen, Menen, Belgium.

Claudia De Valck (C)

Department of Otorhinolaryngology, AZ Turnhout, Turnhout, Belgium.

Robbe Calcoen (R)

CAR Stappie, Ostend, Belgium.

Nele Lemkens (N)

Department of Otorhinolaryngology, ZOL Genk, Genk, Belgium.

Okan Öz (O)

Ear, Nose, and Throat Clinic, The Eargroup, Antwerp, Belgium.

Mieke De Bock (M)

CAR Sint-Lievenspoort, Ghent, Belgium.

Lisa Haverbeke (L)

Department of Otorhinolaryngology, ASZ Aalst, Aalst, Belgium.

Christoph Verhoye (C)

Department of Otorhinolaryngology, AZ Sint-Lucas Bruges, Bruges, Belgium.

Frank Declau (F)

Department of Otorhinolaryngology, GZA Sint-Vincentius, Antwerp, Belgium.

Benoit Devroede (B)

Department of Otorhinolaryngology, Queen Fabiola Children's University Hospital, Brussels, Belgium.

Glen Forton (G)

Department of Otorhinolaryngology, AZ Delta Roeselare, Roeselare, Belgium.

Naima Deggouj (N)

Institute of Neurosciences and Department of Otorhinolaryngology, Université Catholique de Louvain, Brussels, Belgium.

Leen Maes (L)

Faculty of Medicine and Health Sciences, Departments of Rehabilitation Sciences, Ghent University, Ghent, Belgium.
Department of Otorhinolaryngology, Ghent University Hospital, Ghent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH